A Multicentre Randomized Phase II Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advanced Urothelial Cancer Progressing on or After a Platinum Containing Regimen.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- Acronyms BL12
- 28 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
- 06 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 12 Mar 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.